SLGL
Sol-Gel Technologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$64.98
+1.14%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 154.72x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.42x
- Price / sales
- 118.52x
- Price / cash flow
- 660.70x
Enterprise value
- Enterprise value
- $165.6M
- EV / sales
- 92.25x
- EV / EBITDA
- -9.53x
- EV / EBIT
- -9.35x
- Market cap
- $212.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026